CURE recently visited Jersey Shore University Medical Center in Neptune, NJ to speak with Dr. Gregory Tiesi about Trans ...
The U.S. Food and Drug Administration (FDA) has granted traditional full approval to the CAR-T cell therapy Tecartus ...
The study's safety findings suggest that the physical "number" of a patient's age is less important than their functional ...
A study led by researchers at a community hospital in Sapporo, Japan found that comprehensive genomic testing using a ...
That choice was not available to me. My perspective on genetic risk isn't theoretical. My mother, Ioanna, died when I was 9.
Author and survivor Parul Somani shares how patients with breast cancer can find peace of mind when clinical certainty is ...
Dr. Coleman: For patients with recurrent ovarian cancer, the main benefit of adding Lifyorli to nab-paclitaxel is controlling ...
U.S. Food and Drug Administration (FDA) has approved a PD-L1 companion diagnostic test for patients with esophageal cancer or ...
New ELCC 2026 data show longer survival, better brain metastases control and more personalized treatment options for patients ...
In this segment, Dr. Gregory Vidal outlines what a typical first-line treatment plan looks like for patients with ER-positive ...
A couple opens up about navigating cancer care, advocating for themselves and balancing caregiver responsibilities with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results